Salvatore Giovine
2021
In 2021, Salvatore Giovine earned a total compensation of $1.9M as Chief Financial Officer at Xilio Therapeutics.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Non-Equity Incentive Plan | $193,600 |
| Option Awards | $1,388,505 |
| Salary | $291,565 |
| Other | $299 |
| Total | $1,923,969 |
Giovine received $1.4M in option awards, accounting for 72% of the total pay in 2021.
Giovine also received $50K in bonus, $193.6K in non-equity incentive plan, $291.6K in salary and $299 in other compensation.
Rankings
In 2021, Salvatore Giovine's compensation ranked 6,182nd out of 12,415 executives tracked by ExecPay. In other words, Giovine earned more than 50.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,182 out of 12,415 | 50th |
Division Manufacturing | 2,621 out of 5,505 | 52nd |
Major group Chemicals And Allied Products | 1,144 out of 2,375 | 52nd |
Industry group Drugs | 1,018 out of 2,096 | 51st |
Industry Pharmaceutical Preparations | 736 out of 1,546 | 52nd |
Source: SEC filing on April 26, 2022.
Giovine's colleagues
We found two more compensation records of executives who worked with Salvatore Giovine at Xilio Therapeutics in 2021.